Skip to content
Search

Latest Stories

AI spots heart conditions before symptoms appear

The AI tool, developed by researchers at the University of Leeds and Leeds Teaching Hospitals NHS Trust, is part of the Find-AF trial

AI spots heart conditions before symptoms appear

The trial sees the AI system scanning GP records at multiple surgeries in West Yorkshire (Photo for representation: iStock)

A NEW artificial intelligence (AI) tool is revolutionising the early detection of atrial fibrillation (AF), a common heart condition linked to a heightened risk of stroke.

This innovative approach is currently undergoing trials in West Yorkshire, where it analyses patient records to spot early warning signs of AF, even before symptoms develop, reported the Telegraph.


AF, which causes an irregular and often rapid heart rate, affects approximately 1.6 million people in the UK. However, experts from the British Heart Foundation (BHF) estimate that thousands more cases remain undiagnosed. While some patients with AF experience symptoms such as palpitations, dizziness, or fatigue, many remain asymptomatic and unaware of their condition. Early diagnosis is crucial, as timely treatment can significantly reduce the risk of stroke.

The AI tool, developed by researchers at the University of Leeds and Leeds Teaching Hospitals NHS Trust, is part of the Find-AF trial funded by the BHF and Leeds Hospitals Charity.

By analysing anonymised health records from over 2.1 million individuals, the algorithm has been trained to recognise patterns and risk factors indicative of potential AF cases. It was further validated using data from an additional 10 million medical records.

The trial sees the AI system scanning GP records at multiple surgeries in West Yorkshire. Patients identified as high-risk are invited for further testing. They are given handheld electrocardiography (ECG) devices to monitor their heart rhythm twice daily over four weeks or whenever they experience palpitations. If the ECG detects AF, the results are shared with their GP to discuss potential treatments.

John Pengelly, a former Army captain, credits the AI tool for identifying his elevated risk of AF. “I’m really grateful,” he said. “Now, I just take a couple of pills a day to lower my stroke risk.”

Prof Chris Gale, a cardiovascular medicine specialist at the University of Leeds, explained the importance of early detection: “All too often, the first sign of undiagnosed AF is a stroke, which can have devastating consequences for patients and their families. Identifying AF earlier can prevent such outcomes and reduce the financial burden on healthcare services.”

The AI system calculates risk using a combination of factors, including age, sex, ethnicity, and pre-existing conditions like high blood pressure or diabetes. This targeted approach aims to make the diagnosis process more efficient and accessible. The trial’s success could pave the way for a nationwide rollout, potentially preventing thousands of strokes annually. AF is believed to contribute to around 20,000 strokes in the UK each year.

Dr Sonya Babu-Narayan, associate medical director at the BHF, highlighted the potential impact of this technology: “By leveraging routinely collected healthcare data and predictive algorithms, this research offers an exciting opportunity to identify more individuals at risk of AF and reduce their stroke risk.”

Health secretary Wes Streeting recently praised the transformative potential of AI in healthcare, noting its ability to “predict and prevent illness”.

More For You

Asian community

Menopause is a universal transition - one every woman will experience in her lifetime

iStock

Breaking the silence: Why Asian women must talk about menopause

Kiran Singh

For many women in the Asian community, the journey through perimenopause and menopause is still shrouded in silence, confusion, and, at times, shame. It’s often seen as something we just have to “put up with” quietly, as though struggling through it alone is a badge of honour. But the truth is, menopause is a universal transition - one every woman will experience in her lifetime - and it is time we start talking about it, especially within our cultural communities where silence often masks suffering.

We all go through it - so why don’t we talk about it?

Menopause doesn’t arrive overnight. For most women, it begins subtly during perimenopause, which can start as early as your late 30s or early 40s and last for several years. According to the NHS and the National Institute for Health and Care Excellence (NICE), over 30 recognised symptoms of perimenopause range from hot flushes and night sweats to anxiety, low mood, brain fog, and joint pain.

Keep ReadingShow less
Great guide to building healthy eating habits

Good nutrition is the foundation of an active lifestyle

Great guide to building healthy eating habits

Nesreen G and Jayeeta Dutta

PHYSICAL exercise is important when it comes to fitness, but what we fuel our body with plays an equally vital role in achieving sustainable results.

The key to long-term fitness success is developing mindful eating habits that nourish the body and soul, enhance performance and help maintain a healthy lifestyle. This does not necessarily mean following a restrictive diet or complicated meal plans. It is about finding a sustainable balance that works for you.

Keep ReadingShow less
The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Sinha’s message was one of resilience and realism

Getty

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Paul Sinha, known to viewers of ITV’s The Chase as “The Sinnerman,” has spoken candidly about his experience living with Parkinson’s disease. During an appearance on Loose Women on Thursday, 17 April, the comedian and quizzer reflected on his journey from diagnosis to managing the condition day to day.

Sinha, who was diagnosed with the progressive neurological disorder in 2019, revealed that his earliest symptoms were not what many would typically associate with Parkinson’s.

Keep ReadingShow less
MRI

Individuals with certain metabolic conditions may be more prone to this process

Getty

MRI injection linked to rare deadly health risk, study finds

A new study has raised concerns over the use of a common chemical injected during MRI scans, suggesting it may contribute to a potentially fatal complication in rare cases.

Researchers from the University of New Mexico have found that gadolinium – a toxic rare earth metal used in MRI contrast agents – can interact with oxalic acid found in many foods to form nanoparticles in human tissues. These particles could potentially lead to serious health problems affecting organs such as the kidneys.

Keep ReadingShow less
Capivasertib: New NHS Pill Slows Incurable Breast Cancer Progression

Around 3,000 women each year could benefit from the treatment

iStock

New pill Capivasertib slows incurable breast cancer progression, now on NHS

A new drug for one of the most common forms of advanced breast cancer, capivasertib, is now available on the NHS in England. Around 3,000 women each year could benefit from the treatment after clinical trials showed it can slow the progression of the disease and shrink tumours in a significant number of patients.

The National Institute for Health and Care Excellence (NICE) has approved capivasertib for NHS funding. It is one of a range of treatment options offered to patients whose breast cancer has spread and is no longer curable.

Keep ReadingShow less